BELLEROPHON THERAPEUTICS LLC

Inactive Instrument

Analyst Reco. Bellerophon Therapeutics LLC Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
-	-

12:09pm	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 25	North American Morning Briefing : More Tech -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : More Tech -2-	Apr. 25	DJ
North American Morning Briefing : Stocks Futures Steady on Rates Optimism	Nov. 20	DJ
HC Wainwright Adjusts Bellerophon Therapeutics Price Target to $2 From $30, Maintains Buy Rating	23-06-06	MT
Brookline Capital Downgrades Bellerophon Therapeutics to Hold From Buy	23-06-06	MT
Laidlaw Downgrades Bellerophon Therapeutics to Hold From Buy	23-06-06	MT
Laidlaw Initiates Bellerophon Therapeutics at Buy With $35 Price Target	23-05-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer